Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Jun. 30, 2023
Assets:    
Cash and cash equivalents $ 15,200 $ 43,104
Accounts receivable, net 4,448 4,753
Inventory 5,104 7,548
Other current assets 3,811 4,440
Total current assets 28,563 59,845
Property and equipment, net 53,198 57,826
Goodwill 6,508 14,559
Intangibles, net 13,220 15,241
Operating lease right-of-use asset, net 1,039 1,374
Other assets 71 72
Total Assets 102,599 148,917
Current Liabilities:    
Accounts payable and accrued expenses 15,968 17,027
Deferred revenue 95 105
Promissory note payable 1,667  
Operating lease liability 498 439
Total current liabilities 18,228 17,571
Long-term Liabilities:    
Convertible notes payable, net 41,753 43,347
Promissory notes payable 667
Operating lease liability 596 976
Other long-term liabilities 117 117
Total Long-Term liabilities 42,466 45,107
Total Liabilities 60,694 62,678
Commitments and Contingencies (Note 14)
Stockholders’ Equity    
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 175,000,000 shares authorized; 98,654,282, and 72,154,647 shares issued and outstanding at March 31, 2024 and June 30, 2023, respectively 99 72
Additional paid in capital 371,510 356,522
Accumulated deficit (329,704) (270,355)
Total Stockholders’ Equity 41,905 86,239
Total Liabilities and Stockholders’ Equity $ 102,599 $ 148,917